Difficulty: Medium
Average Score: 68%
Practice
All are true about genotype - phenotype correlation in Brugada syndrome, except
Correct answer
D
Rationale
In the context of Brugada syndrome, understanding the genotype-phenotype correlation is crucial for diagnosis and management. The correct answer, option D, states that there are no major therapeutic implications of genetic testing in Brugada syndrome. This is because the current treatment approach for Brugada syndrome focuses on managing symptoms and reducing the risk of sudden cardiac death rather than targeting specific genetic mutations.
Option A states that SCN5A mutation is associated with a short PR interval, which is true. SCN5A mutations are commonly linked to Brugada syndrome and can manifest with characteristic electrocardiogram findings such as a short PR interval.
Option B suggests that LTCC mutation is associated with a short QT interval, which is incorrect. LTCC mutations are not typically associated with Brugada syndrome; instead, they are more commonly linked to long QT syndrome.
Option C mentions that the yield of genetic testing is low (25%). While the yield of genetic testing in Brugada syndrome may vary, it is generally higher than 25%. Genetic testing can be valuable in confirming a diagnosis, identifying at-risk family members, and guiding management strategies in some cases.
Educationally, understanding the genotype-phenotype correlation in Brugada syndrome highlights the importance of personalized medicine in pediatric cardiovascular nursing. It underscores the need for healthcare providers to stay abreast of advancements in genetic testing and tailor treatment approaches based on individual patient characteristics.
Option A states that SCN5A mutation is associated with a short PR interval, which is true. SCN5A mutations are commonly linked to Brugada syndrome and can manifest with characteristic electrocardiogram findings such as a short PR interval.
Option B suggests that LTCC mutation is associated with a short QT interval, which is incorrect. LTCC mutations are not typically associated with Brugada syndrome; instead, they are more commonly linked to long QT syndrome.
Option C mentions that the yield of genetic testing is low (25%). While the yield of genetic testing in Brugada syndrome may vary, it is generally higher than 25%. Genetic testing can be valuable in confirming a diagnosis, identifying at-risk family members, and guiding management strategies in some cases.
Educationally, understanding the genotype-phenotype correlation in Brugada syndrome highlights the importance of personalized medicine in pediatric cardiovascular nursing. It underscores the need for healthcare providers to stay abreast of advancements in genetic testing and tailor treatment approaches based on individual patient characteristics.